Products (gDNA and cell lines)
|Gene||Mutated base||Mutated amino acid||Genotype|
Services (Custom cell lines)
For rare tumor mutation sites or other indications, CRISPR-U™ technology can efficiently introduce target mutations into cell lines.
CRISPR-U™ is a gene editing technology independently developed by Ubigene which has higher gene cutting efficiency than ordinary CRISPR/Cas9 technology and can greatly improve the efficiency of homologous recombination, easily achieving gene knockout (KO), point mutation (PM) and knockin (KI) at the cellular and animal levels. Taking advantage of CRISPR-U™ technology, Ubigene has successfully achieved gene editing on more than 200 kinds of cell lines. Providing high-quality of experimental strategy and vector with the abundant experience of more than 200 cell lines and 5000 genes; Significantly increasing the transfection rate — thanks to the mature transfection system as well as the special transfection medium; Improving the single-cell clone formation rate by at least 30% with the great help of the single-cell clone culture medium; Easily realizing the batch validation of single-cell clones when growing in 96-well plate with the support of the single-cell clone validation kit. Ubigene comprehensively optimized all aspects of the gene-editing experiment to ensure the effective improvement of the success rate of gene-editing experiments and easy delivery of positive clones!